136 related articles for article (PubMed ID: 16740140)
1. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.
Forrest MS; Skibola CF; Lightfoot TJ; Bracci PM; Willett EV; Smith MT; Holly EA; Roman E
Br J Haematol; 2006 Jul; 134(2):180-3. PubMed ID: 16740140
[TBL] [Abstract][Full Text] [Related]
2. A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
Hosgood HD; Purdue MP; Wang SS; Zheng T; Morton LM; Lan Q; Menashe I; Zhang Y; Cerhan JR; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Schenk M; Zahm SH; Chatterjee N; Chanock SJ; Rothman N; Hartge P; Armstrong B
Br J Haematol; 2011 Mar; 152(6):721-6. PubMed ID: 21250972
[TBL] [Abstract][Full Text] [Related]
3. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity and non-Hodgkin's lymphoma (NHL) related genes in a nested case-control study for gastric cancer risk.
Park SK; Yang JJ; Oh S; Cho LY; Ma SH; Shin A; Ko KP; Park T; Yoo KY; Kang D
PLoS One; 2012; 7(9):e45274. PubMed ID: 23028900
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
Rothman N; Skibola CF; Wang SS; Morgan G; Lan Q; Smith MT; Spinelli JJ; Willett E; De Sanjose S; Cocco P; Berndt SI; Brennan P; Brooks-Wilson A; Wacholder S; Becker N; Hartge P; Zheng T; Roman E; Holly EA; Boffetta P; Armstrong B; Cozen W; Linet M; Bosch FX; Ennas MG; Holford TR; Gallagher RP; Rollinson S; Bracci PM; Cerhan JR; Whitby D; Moore PS; Leaderer B; Lai A; Spink C; Davis S; Bosch R; Scarpa A; Zhang Y; Severson RK; Yeager M; Chanock S; Nieters A
Lancet Oncol; 2006 Jan; 7(1):27-38. PubMed ID: 16389181
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.
Lan Q; Zheng T; Shen M; Zhang Y; Wang SS; Zahm SH; Holford TR; Leaderer B; Boyle P; Chanock S
Hum Genet; 2007 Apr; 121(2):161-8. PubMed ID: 17149600
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk.
Skibola CF; Bracci PM; Paynter RA; Forrest MS; Agana L; Woodage T; Guegler K; Smith MT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2391-401. PubMed ID: 16214922
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
Lan Q; Wang SS; Menashe I; Armstrong B; Zhang Y; Hartge P; Purdue MP; Holford TR; Morton LM; Kricker A; Cerhan JR; Grulich A; Cozen W; Zahm SH; Yeager M; Vajdic CM; Schenk M; Leaderer B; Yuenger J; Severson RK; Chatterjee N; Chanock SJ; Zheng T; Rothman N
Br J Haematol; 2011 May; 153(3):341-50. PubMed ID: 21418175
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N
Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630
[TBL] [Abstract][Full Text] [Related]
16. Association between polymorphic sites in thymidylate synthase gene and risk of non-Hodgkin lymphoma: a systematic review and pooled analysis.
Zhou JY; Shi R; Yu HL; Zeng Y; Zheng WL; Ma WL
Leuk Lymphoma; 2012 Oct; 53(10):1953-60. PubMed ID: 22397721
[TBL] [Abstract][Full Text] [Related]
17. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
18. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
[TBL] [Abstract][Full Text] [Related]
20. Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.
Zhang Y; Xia ZG; Zhu JH; Chen MB; Wang TM; Shen WX; He J
Mol Genet Genomics; 2015 Dec; 290(6):2063-73. PubMed ID: 25977148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]